|
⚲
|
| Keyboard |
| Oliger Christy J
✚
|
|
|---|---|
| CIK # | 0001822092 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001822092] | |
| 4 | [0001822092] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lava Therapeutics NV LVTX
Share Options (Right to Buy) · derivative
|
2025-11-13 | Disposed to issuer | 33,390 | $0.00 | |
|
Nuvalent Inc NUVL
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 6,119 | $0.00 | |
|
Nuvalent Inc NUVL
Class A Common Stock
|
2025-06-18 | Grant | 3,971 | $0.00 | |
|
Karyopharm Therapeutics Inc KPTI
Nonstatutory Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 4,600 | $0.00 | |
|
Vera Therapeutics Inc VERA
Stock Option (right to buy) · derivative
|
2025-05-14 | Grant | 14,000 | $0.00 | |
|
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 32,000 | $0.00 | |
|
Lava Therapeutics NV LVTX
Common Shares (Right to Buy) · derivative
|
2025-02-13 | Grant | 33,390 | $0.00 | |
|
Vera Therapeutics Inc VERA
Stock Option (right to buy) · derivative
|
2024-06-07 | Grant | 25,000 | $0.00 | |
|
Karyopharm Therapeutics Inc KPTI
Nonstatutory Stock Option (right to buy) · derivative
|
2024-05-29 | Grant | 69,000 | $0.00 | |
|
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
|
2024-04-01 | Grant | 32,000 | $0.00 | |
|
RayzeBio Inc RYZB
Employee Stock Option (Right to Buy) · derivative
|
2024-02-26 | Disposed to issuer | 114,579 | ||
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-09-26 | Disposed to issuer | 5,565 | ||
|
Reata Pharmaceuticals Inc RETA
Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 5,620 | ||
|
Reata Pharmaceuticals Inc RETA
Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 5,000 | ||
|
Reata Pharmaceuticals Inc RETA
Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 106 | ||
|
Reata Pharmaceuticals Inc RETA
Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 2,137 | ||
|
Reata Pharmaceuticals Inc RETA
Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 180 | ||
|
Reata Pharmaceuticals Inc RETA
Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 1,250 | ||
|
Reata Pharmaceuticals Inc RETA
Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 10,000 | ||
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-06-07 | Grant | 1,682 | $93.61 | 157,452 |
| showing 20 of 37 most recent transactions | |||||